Dr David Spigel discusses challenges and solutions to incorporating cancer biomarkers into patient care, including finding pathology resources to do the testing, issues around reimbursement, and educating colleagues on the value and operational aspects of biomarker testing in delivering personalized therapy to patients with cancer.
Related Items
Web Exclusives published on December 9, 2021 in ASCO, Biliary Tract Cancer, Cholangiocarcinoma, Pancreatic Cancer
2020 Year in Review - Lung Cancer published on January 20, 2021 in Lung Cancer
2020 Year in Review - Lung Cancer published on January 20, 2021 in Lung Cancer
Last modified: July 22, 2021
